Permax
Brand names,
Permax
Analogs
Permax
Brand Names Mixture
Permax
Chemical_Formula
C19H26N2S
Permax
RX_link
http://www.rxlist.com/cgi/generic2/pergol.htm
Permax
fda sheet
Permax
msds (material safety sheet)
Permax
Synthesis Reference
No information avaliable
Permax
Molecular Weight
314.489 g/mol
Permax
Melting Point
207.5 oC
Permax
H2O Solubility
No information avaliable
Permax
State
Solid
Permax
LogP
4.02
Permax
Dosage Forms
Tablet
Permax
Indication
Indicated as adjunctive treatment to levodopa/carbidopa in the management of the signs and symptoms of Parkinson’s disease.
Permax
Pharmacology
Pergolide is an ergot derivative dopamine receptor agonist at both D1 and D2 receptor sites. Pergolide is 10 to 1,000 times more potent than bromocriptine on a milligram per milligram basis in various in vitro and in vivo test systems. Pergolide mesylate inhibits the secretion of prolactin in humans; it causes a transient rise in serum concentrations of growth hormone and a decrease in serum concentrations of luteinizing hormone. In Parkinson’s disease, pergolide mesylate is believed to exert its therapeutic effect by directly stimulating postsynaptic dopamine receptors in the nigrostriatal system.
Permax
Absorption
Significant amount may be absorbed (evidence on bioavailability still lacking).
Permax
side effects and Toxicity
Oral, rat LD50: 15 mg/kg. Symptoms of overdose include nausea, vomiting, convulsions, decreased blood pressure, and CNS stimulation.
Permax
Patient Information
Permax
Organisms Affected
Humans and other mammals